Combining the recyclability of heterogeneous catalysts with the high activity of ligated homogeneous catalysts for the production of complex organic molecules is a cardinal goal of catalyst development. We have investigated the activity of ultra-fine Pd clusters bound to vacancy defective sites in graphene and found that the defective graphene both serves as a support to stabilize the recyclable catalyst, and also functions as a ligand enhancing the catalytic activity. In this paper, we report computational and experimental results that provide insights into the nature of the interfacial interactions between metal nanoparticles and defect sites on the graphene surface. Theoretical investigations reveal that while the vacancy/void sites on the graphene surface strongly bind to the metal clusters providing enhanced stability against leaching, graphene also serves as a reservoir of electron density that effectively reduces the activation energy of specific steps within the catalytic cycle. Furthermore, multiple experimental methods were used to unambiguously demonstrate that these cross-coupling reactions are occurring at the Pd/G catalyst surface.
8 March 2018 in Beilstein Journal of Organic Chemistry
Numerous synthetic methods for the continuous preparation of fine chemicals and active pharmaceutical ingredients (API’s) have been reported in recent years resulting in a dramatic improvement in process efficiencies. Herein we report a highly efficient continuous synthesis of the antimalarial drug hydroxychloroquine (HCQ). Key improvements in the new process include the elimination of protecting groups with an overall yield improvement of 52% over the current commercial process. The continuous process employs a combination of packed bed reactors with continuous stirred tank reactors for the direct conversion of the starting materials to the product. This high-yielding, multigram-scale continuous synthesis provides an opportunity to achieve increase global access to hydroxychloroquine for treatment of malaria.
Fundamental elements of process intensification were applied to generate efficient batch and continuous syntheses of the high-volume HIV drug nevirapine.